OTCMKTS:CVALF

Covalon Technologies Q3 2026 Earnings Results & Report

Covalon Technologies logo
$2.93 -0.01 (-0.34%)
As of 11/16/2026 01:47 PM Eastern

Covalon Technologies beat analyst expectations on both earnings and revenue in its Q3 2026 results, released August 27, 2026. The company reported EPS of $0.07 versus the $0.0141 consensus estimate, while revenue of $7.07 million topped the $6.65 million estimate by $418.00 thousand.

Earnings Announcement Details

Quarter
Q3 2026
Report Date
Time
Before Market Opens

Covalon Technologies EPS Results

Actual EPS
$0.07
Consensus EPS
$0.0141
Beat/Miss
Beat by +$0.0559
One Year Ago EPS
N/A
EPS Beat Rate
4 of last 5 quarters

Covalon Technologies Revenue Results

Actual Revenue
$7.07 million
Expected Revenue
$6.65 million
Beat/Miss
Beat by +$418.00 thousand
YoY Revenue Growth
N/A

Upcoming Earnings

Covalon Technologies' next earnings date is estimated for Thursday, December 17, 2026, based on past reporting schedules.

Conference Call Resources

Covalon Technologies Q3 2026 Earnings FAQ

Covalon Technologies (OTCMKTS:CVALF) reported earnings of $0.07 per share for Q3 2026, beating the consensus estimate of $0.0141. The report was announced on Thursday, August 27, 2026.

Covalon Technologies reported revenue of $7.07 million for Q3 2026, against a consensus estimate of $6.65 million.

Covalon Technologies' next earnings date is estimated for Thursday, December 17, 2026. MarketBeat tracks confirmed and estimated earnings dates for Covalon Technologies on the company's earnings history page.

Covalon Technologies Earnings Headlines

Covalon Technologies Ltd. (OTCMKTS:CVALF) Stock Short Interest Jumps 79.4%
Trump’s EO to send this $5 stock ripping higher…?
President Trump's December executive order declared space a national security and economic priority, fueling a race among SpaceX, Blue Origin, and others to build massive satellite constellations. One tiny firm holds the patented tech required to transmit satellite data to Earth at scale - and it reportedly powers SpaceX's most profitable division. Shares trade for under 5 dollars. Former JPMorgan wealth manager Ross Givens says it's the most uniquely positioned stock he's seen in 20 years of trading.tc pixel
Covalon Reports Fiscal 2026 Third Quarter Results
Covalon Technologies Ltd CVALF
See More Covalon Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Covalon Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Covalon Technologies and other key companies, straight to your email.

About Covalon Technologies

Covalon Technologies (OTCMKTS:CVALF) Inc. is a Canadian medical technology company focused on wound care, infection prevention and medical coatings. It develops, manufactures and markets products for healthcare providers and medical-device manufacturers.

Its products include wound dressings and skin-care products, antimicrobial dressings for vascular access sites, and dressings designed to help protect surgical sites. The company also provides coating technologies and related services for medical devices.

Based in Mississauga, Ontario, Covalon serves customers and business partners in Canada, the United States and other international markets.

View Covalon Technologies Profile